By vgreene, 4 March, 2021 Study considerations small sample size SOC evolved during trial significant baseline differences despite randomization
By vgreene, 4 March, 2021 Study considerations non randomized inverse probability weighting significant imbalances btwn groups number of TCZ doses not recorded CS duration not recorded missing data for some key variables
By vgreene, 4 March, 2021 KEY FINDINGS early TCZ use assoc w lower in hospital mortality in critically ill
By vgreene, 4 March, 2021 Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID 19
By vgreene, 4 March, 2021 Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID 19
By vgreene, 4 March, 2021 Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID 19
By vgreene, 4 March, 2021 Study considerations randomized but open label small sample size study interrupted due to low enrollment excluded pts at risk for ICU admission significant imbalances btwn groups incl antiviral use and baseline labs
